vs

Side-by-side financial comparison of Health In Tech, Inc. (HIT) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

RETRACTABLE TECHNOLOGIES INC is the larger business by last-quarter revenue ($9.4M vs $9.1M, roughly 1.0× Health In Tech, Inc.). Health In Tech, Inc. runs the higher net margin — -4.0% vs -24.9%, a 20.8% gap on every dollar of revenue.

Tetra Tech, Inc. is an American consulting and engineering services firm based in Pasadena, California. The company provides consulting, engineering, program management, and construction management services in the areas of water, environment, infrastructure, resource management, energy, and international development.

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

HIT vs RVP — Head-to-Head

Bigger by revenue
RVP
RVP
1.0× larger
RVP
$9.4M
$9.1M
HIT
Higher net margin
HIT
HIT
20.8% more per $
HIT
-4.0%
-24.9%
RVP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIT
HIT
RVP
RVP
Revenue
$9.1M
$9.4M
Net Profit
$-302.6K
$-2.3M
Gross Margin
45.3%
-16.2%
Operating Margin
-5.9%
-81.7%
Net Margin
-4.0%
-24.9%
Revenue YoY
4.0%
Net Profit YoY
-162.3%
EPS (diluted)
$-0.01
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIT
HIT
RVP
RVP
Q4 25
$9.1M
$9.4M
Q3 25
$9.9M
$10.1M
Q2 25
$9.6M
$10.4M
Q1 25
$8.9M
$8.3M
Q4 24
$9.1M
Q3 24
$10.3M
Q2 24
$6.0M
Q1 24
$7.6M
Net Profit
HIT
HIT
RVP
RVP
Q4 25
$-302.6K
$-2.3M
Q3 25
$452.2K
$371.0K
Q2 25
$630.6K
$-87.5K
Q1 25
$498.6K
$-10.5M
Q4 24
$3.8M
Q3 24
$-1.9M
Q2 24
$-14.2M
Q1 24
$429.4K
Gross Margin
HIT
HIT
RVP
RVP
Q4 25
45.3%
-16.2%
Q3 25
51.8%
16.7%
Q2 25
65.9%
-1.0%
Q1 25
59.9%
-0.0%
Q4 24
-27.5%
Q3 24
-0.1%
Q2 24
-7.0%
Q1 24
25.0%
Operating Margin
HIT
HIT
RVP
RVP
Q4 25
-5.9%
-81.7%
Q3 25
6.0%
-36.2%
Q2 25
8.7%
-49.1%
Q1 25
7.7%
-56.4%
Q4 24
-79.6%
Q3 24
-49.6%
Q2 24
-95.6%
Q1 24
-39.3%
Net Margin
HIT
HIT
RVP
RVP
Q4 25
-4.0%
-24.9%
Q3 25
4.6%
3.7%
Q2 25
6.6%
-0.8%
Q1 25
5.6%
-126.6%
Q4 24
41.6%
Q3 24
-18.6%
Q2 24
-234.9%
Q1 24
5.7%
EPS (diluted)
HIT
HIT
RVP
RVP
Q4 25
$-0.01
$-0.09
Q3 25
$0.01
$0.01
Q2 25
$0.01
$0.00
Q1 25
$0.01
$-0.35
Q4 24
$0.14
Q3 24
$-0.07
Q2 24
$-0.48
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIT
HIT
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$7.7M
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$17.1M
$74.4M
Total Assets
$23.1M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIT
HIT
RVP
RVP
Q4 25
$7.7M
$2.6M
Q3 25
$8.0M
$3.4M
Q2 25
$8.1M
$3.0M
Q1 25
$7.6M
$3.4M
Q4 24
$4.2M
Q3 24
$3.9M
Q2 24
$6.9M
Q1 24
$10.0M
Total Debt
HIT
HIT
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HIT
HIT
RVP
RVP
Q4 25
$17.1M
$74.4M
Q3 25
$17.2M
$76.8M
Q2 25
$16.4M
$76.5M
Q1 25
$14.2M
$76.6M
Q4 24
$87.2M
Q3 24
$83.5M
Q2 24
$85.4M
Q1 24
$99.7M
Total Assets
HIT
HIT
RVP
RVP
Q4 25
$23.1M
$142.6M
Q3 25
$22.8M
$146.4M
Q2 25
$22.2M
$147.1M
Q1 25
$21.3M
$149.3M
Q4 24
$160.7M
Q3 24
$157.8M
Q2 24
$160.7M
Q1 24
$176.0M
Debt / Equity
HIT
HIT
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIT
HIT
RVP
RVP
Operating Cash FlowLast quarter
$3.1M
$-596.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIT
HIT
RVP
RVP
Q4 25
$3.1M
$-596.5K
Q3 25
$674.0K
$-1.3M
Q2 25
$1.5M
$-3.7M
Q1 25
$527.4K
$-1.5M
Q4 24
$-1.1M
Q3 24
$-5.7M
Q2 24
$-2.7M
Q1 24
$-2.0M
Free Cash Flow
HIT
HIT
RVP
RVP
Q4 25
Q3 25
$-1.3M
Q2 25
$-4.1M
Q1 25
$-1.6M
Q4 24
$-1.4M
Q3 24
$-6.5M
Q2 24
$-2.8M
Q1 24
$-2.2M
FCF Margin
HIT
HIT
RVP
RVP
Q4 25
Q3 25
-13.4%
Q2 25
-38.9%
Q1 25
-18.8%
Q4 24
-15.5%
Q3 24
-63.0%
Q2 24
-46.8%
Q1 24
-29.6%
Capex Intensity
HIT
HIT
RVP
RVP
Q4 25
Q3 25
0.9%
Q2 25
3.2%
Q1 25
1.0%
Q4 24
3.3%
Q3 24
7.7%
Q2 24
2.0%
Q1 24
3.0%
Cash Conversion
HIT
HIT
RVP
RVP
Q4 25
Q3 25
1.49×
-3.39×
Q2 25
2.35×
Q1 25
1.06×
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIT
HIT

Revenues From Fees$6.5M71%
Other$1.6M18%
Revenues From Underwriting Modeling ICE$1.0M11%

RVP
RVP

Segment breakdown not available.

Related Comparisons